| Cherish Douglas, | |
|
5965 S 900 E, Murray, UT 84121-1720 | |
| (801) 263-7138 | |
| Not Available |
| Full Name | Cherish Douglas |
|---|---|
| Gender | Female |
| Speciality | Counselor |
| Location | 5965 S 900 E, Murray, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043618481 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Cherish Douglas, 5965 S 900 E, Murray, UT 84121-1720 Ph: (801) 263-7138 | Cherish Douglas, 5965 S 900 E, Murray, UT 84121-1720 Ph: (801) 263-7138 |
News Archive
Individuals and organizations providing or increasing access to quality radiological services for patients in low- to middle-income countries and underserved areas of the United States are encouraged to apply for the American College of Radiology Foundation's new Global Humanitarian Awards.
An American Cancer Society study finds pipe smoking confers a similar risk of cancer and other disease as cigar smoking. The study, the largest and most precise to date of the risks of pipe smoking, appears in the June 2 issue of the Journal of the National Cancer Institute.
Professor John Walker-Smith had been found guilty of professional misconduct following claims he took part in unapproved research that suggested links between the vaccine, bowel disease and autism. Professor Walker-Smith lost his license to practice in May 2010 along with Dr Andrew Wakefield, who led the research. A General Medical Council's ‘fitness to practice' panel found both men guilty of misconduct over the way the work was conducted after 217 days of deliberation – the longest disciplinary case in the body's 150- year history.
In a database study of nearly 26,000 beneficiaries of Tricare, the military health system, those taking statin drugs to control their cholesterol were 87 percent more likely to develop diabetes.
Echoing recent FDA warnings, a research group from Northern Ireland cautions against over-aggressive use of a group of drugs called "erythropoiesis-stimulating agents" (ESAs) to treat anemia in some cancer patients, according to a commentary in the April issue of The Oncologist, published by AlphaMed Press.
› Verified 6 days ago
Jill Sorensen, Counselor Medicare: Not Enrolled in Medicare Practice Location: 5965 S 900 E, Murray, UT 84121 Phone: 801-263-7138 | |
Mira Wiswell, Counselor Medicare: Not Enrolled in Medicare Practice Location: 5965 S 900 E, Murray, UT 84121 Phone: 801-263-7138 | |
Barbara Burke, CRC, LVRC Counselor Medicare: Not Enrolled in Medicare Practice Location: 5965 S 900 E, Murray, UT 84121 Phone: 801-263-7138 | |
Britanee Montano, Counselor Medicare: Not Enrolled in Medicare Practice Location: 5965 S 900 E, Murray, UT 84121 Phone: 801-263-7138 | |
Mark Maughan, Counselor Medicare: Not Enrolled in Medicare Practice Location: 5965 S 900 E, Murray, UT 84121 Phone: 801-263-7138 | |
Elana M Olson, LCSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 5796 S 900 E, Murray, UT 84121 Phone: 801-717-6428 | |
Melanie Moreno-rivas, Counselor Medicare: Not Enrolled in Medicare Practice Location: 5965 S 900 E, Murray, UT 84121 Phone: 801-263-7138 |